Court throws out Abbott AIDS-drug claims

Abbott Laboratories won a federal appeals court ruling dismissing claims that the company maintained a monopoly and overcharged for its HIV medicine Norvir, but still faces suits from competitors and drug-buyers over the price of the drug. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.